Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
22.93 USD | +0.58% | 0.00% | +526.50% |
05-24 | Landos Biopharma, Inc.(NasdaqCM:LABP) dropped from S&P TMI Index | CI |
05-23 | AbbVie Completes Acquisition of Landos Biopharma | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+526.50% | 71.68M | |
+54.45% | 58.06B | |
-4.71% | 40.53B | |
+37.26% | 38.99B | |
+13.65% | 26.7B | |
-12.01% | 26.56B | |
-21.54% | 18.98B | |
+1.83% | 12.17B | |
+23.70% | 12B | |
+26.44% | 11.92B |
- Stock Market
- Equities
- LABP Stock
- News Landos Biopharma, Inc.
- Landos Biopharma Appoints Tim Mayleben Interim Chief Executive